ELANCO ANIMAL HEALTH INC (ELAN)
NYSE • Healthcare
Last close at July 21, 2026 at 20:00 UTC
Fundamentals Charts
About ELANCO ANIMAL HEALTH INC
Elanco Animal Health Incorporated is a New York Stock Exchange-listed animal health drugmaker trading as ELAN. The company creates, produces, and commercializes medicines and related products for companion animals and livestock, spanning pet care and farm-animal health, and generated $4.7 billion in revenue in FY2025.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
ELANCO ANIMAL HEALTH INC's Technical Indicators Summary
ELAN is trading at about 25.83 and is broadly supported by rising moving averages across short and long horizons, while momentum indicators such as a strongly positive CCI and a modestly bullish MACD point toward accumulation. ADX near 10.43 indicates the trend lacks conviction, and ATR around 0.94 shows moderate volatility. On-balance volume is positive, lending weight to the momentum readings even as stochastic measures approach extended levels. Technical takeaway: Buy — widespread moving-average support and positive momentum outweigh the weak trend strength.
| Indicator | Value |
|---|---|
RSI (14) | 62.58 |
Stochastic %K (14, 3, 3) | 82.91 |
CCI (20) | 162.84 |
WPR (14) | -20.45 |
Momentum (10) | 0.83 |
MFI | 57.94 |
MACD Level (12, 26) | 0.54 |
Bollinger Bands | $23.35 - $26.10 |
ATR (14) | $0.94 (3.64%) |
ADX (14) | 10.43 |
OBV | 23,052,864 |
Classic Pivot Point | $25.83 |
Fibonacci Pivot Point | $25.83 |
Exponential Moving Averages | $22.41 - $25.28(5 indicators) |
Simple Moving Averages | $23.19 - $25.19(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
ELAN eases into the session up 1.27% from yesterday’s close of 25.14. Sector-level price action is largely a non-event (0.29%), shifting attention to idiosyncratic factors. ELAN climbs on news of Elanco's launch of a new feline CKD treatment, expanding its veterinary product line.
Trading Volume
Above 10d avg 4.0M
4.2M
vs S&P 500 Today
Moderate Outperformance
+0.35%
52-Week Position
Upper range
84.2%
Updated: July 21, 2026 at 20:04 UTC
Quote Summary
ELAN Headlines
Healthcare stocks fall after weak US jobs data
March 6, 2026